timolol has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelmaksoud, A; Filoni, A; Giudice, G; Vestita, M | 1 |
1 other study(ies) available for timolol and HIV Coinfection
| Article | Year |
|---|---|
Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Antiretroviral Therapy, Highly Active; Female; Gels; HIV Infections; Humans; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Timolol | 2017 |